Shinya Yamanaka, MD, recipient of the 2012 Nobel Prize in Medicine and president of the International Society for Stem Cell Research, announced the partnership with Cell Press.[/caption]
The International Society for Stem Cell Research (ISSCR) has chosen Cell Press to publish its new open access journal, Stem Cell Reports. Nobel laureate and ISSCR President Dr. Shinya Yamanaka announced the partnership today at the Roddenberry International Symposium on Cellular Reprogramming in San Francisco.
Stem Cell Reports will provide a new open access venue for important developments ranging from basic advances to clinical translation of stem cell research into appropriate clinical applications.
“We believe the new journal will provide a much-needed forum to highlight new developments and ideas in this rapidly-evolving field,” Dr. Yamanaka said.
As the most prominent scientific society in the stem cell field, the ISSCR provides a platform for the stem cell community to exchange and disseminate information and ideas. With Stem Cell Reports, Cell Press continues to develop the publishing options available to stem cell researchers for communication of their work.
“We welcome the opportunity to partner with societies who are looking to launch new open access journals to extend the ways in which they serve their members and the scientific community,” said Dr. Emilie Marcus, CEO of Cell Press, which is an imprint of Elsevier.
This launch builds on the affiliation between the ISSCR and Cell Stem Cell, a Cell Press journal that launched in 2007 and now has an impact factor of 25.421. Dr. Yamanaka, who won the 2012 Nobel Prize for Physiology and Medicine with Sir John B. Gurdon, is on the Editorial Board of Cell Stem Cell.
The editor of Stem Cell Reports will be Dr. Christine Mummery, Professor of Developmental Biology and Chair of the Department of Anatomy and Embryology at Leiden University Medical Center. Her primary research focus is currently the development and use of stem cells in cardiovascular development and disease. She will be joined by four associate editors and an Editorial Board.
Stem Cell Reports will begin accepting submissions in December for publication in the inaugural issue in June. There will be various types of articles, including full-length papers and shorter formats. Stem Cell Reports’ authors will retain full copyright over their articles, which will be published using Creative Commons licenses.
Cell Press has always placed a high priority on enabling authors to disseminate published research widely and easily. The journal offers a variety of options to make content widely accessible, both for Cell Press-owned titles and for journals published on behalf of learned societies. These options include free featured articles, sponsored-access opportunities, free access to all content after 12 months, and publication in the Cell Press open access journal Cell Reports. (Cell Reports, launched in January, was Cell Press’s first open access journal. Authors and editors talk about it in this Cell Press video for Open Access Week.[note color="#f1f9fc" position="left" width=800 margin=10]
To honor the achievements of Cell and Cell Stem Cell Editorial Board member Shinya Yamanaka and Sir John B. Gurdon, the recipients of the 2012 Nobel Prize in Physiology or Medicine, Cell Press has made the research they published in Cell Press journals free, including Dr. Yamanaka’s groundbreaking 2006 paper in Cell: “Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors.”
For access to more Nobel research, visit Elsevier’s Nobel tribute site.[/note]